Skip to main content

Table 1 Demographic criteria and clinical data of β-thalassemia major patients

From: Global and regional cardiac magnetic resonance feature tracking left ventricular strain analysis in assessing early myocardial disease in β thalassemia major patients

Characteristic

Without MIO

(n = 46)

With MIO

(n = 11)

P-value

Age (yr)

30 (19–45)

24 (18–50)

0.041*

Ferritin (ng/mL)

1,766.5 (480–4,291)

2,500 (870–4,000)

0.190

White blood cell count (× 103/uL)

23 (3.3–158)

22.4 (3.3–47)

0.867

Hemoglobin (g/dL)

7.8 (5.9–10.5)

7.5 (5.3–9.1)

0.125

Platelet count (× 103/uL)

619 (101–1,985)

564 (26–941)

0.356

Alanine transaminase (IU/L)

32.5 (7–114)

48 (7–76)

0.598

Aspartate transferase (IU/L)

47.5 (15–144)

50 (16–121)

0.867

Albumin (gm/dL)

4.0 (1.4–4.9)

3.9 (1.7–4.9)

0.571

  1. Values are presented as median (interquartile range). Mann–Whitney U-test was used to test significance
  2. *P < 0.05